Risk of the incidence of delirium and the utility of antipsychotics for delirium in elderly patients after cardiac surgery
Phase 3
- Conditions
- Eldery patients (more than 65 year-old) scheduled to undergo cardiac surgery
- Registration Number
- JPRN-UMIN000028876
- Lead Sponsor
- Faculty of Life Science, Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 275
Inclusion Criteria
Not provided
Exclusion Criteria
People with severe dementia and visual and hearing disabilities
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence of delirium after cardiac surgery Improvement of DRS-R-98 score 7 days after the administration of antipsychotics
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie delirium incidence in elderly cardiac surgery patients?
How effective are antipsychotics compared to standard-of-care for post-cardiac surgery delirium management?
Are there specific biomarkers that predict delirium risk or antipsychotic response in elderly cardiac surgery patients?
What are the potential adverse events associated with antipsychotic use in elderly post-cardiac surgery patients and how can they be managed?
What combination therapies or alternative drugs show promise in treating post-cardiac surgery delirium compared to the antipsychotics studied in JPRN-UMIN000028876?